Detalhe da pesquisa
1.
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Ann Rheum Dis
; 83(6): 706-719, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499325
2.
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study.
Rheumatology (Oxford)
; 63(1): 93-102, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052534
3.
Cancer risk with tocilizumab/sarilumab, abatacept, and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study.
Rheumatology (Oxford)
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452297
4.
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
J Rheumatol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621792
5.
Physical activity guidance in the rheumatology clinic-what matters for patients with rheumatoid arthritis? A qualitative study.
Rheumatol Int
; 44(1): 181-189, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787914
6.
Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis-a survey based cross-sectional study.
Rheumatol Int
; 44(6): 1119-1131, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563971
7.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813538
8.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953263
9.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423647
10.
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.
Rheumatology (Oxford)
; 62(2): 647-658, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723604
11.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738257
12.
Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritis.
Clin Exp Rheumatol
; 41(9): 1801-1807, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995323
13.
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries.
Ann Rheum Dis
; 81(6): 789-797, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318218
14.
Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark.
Rheumatology (Oxford)
; 61(9): 3711-3722, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864891
15.
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
Rheumatology (Oxford)
; 61(11): 4286-4296, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139178
16.
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering.
Rheumatology (Oxford)
; 61(6): 2398-2412, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636846
17.
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries.
Rheumatology (Oxford)
; 61(9): 3647-3656, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940795
18.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
Rheumatology (Oxford)
; 61(12): 4741-4751, 2022 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323903
19.
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Ann Rheum Dis
; 80(11): 1400-1409, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926921
20.
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Rheumatology (Oxford)
; 60(12): 5549-5559, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748831